Flexion reports Phase IIb OA data for FX006

Flexion Therapeutics Inc. (Woburn, Mass.) said a single intra-articular injection of FX006 significantly improved the magnitude and duration of pain relief at 12 weeks vs. an immediate-release (IR) fo...